AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Pharma, Media, and Regulatory Conflicts
This chapter explores the intricate relationships between pharmaceutical companies, corporate media, and regulatory bodies like the FDA. It critiques the potential conflicts of interest that arise from career transitions between these sectors and discusses how financial incentives shape drug approval processes, particularly regarding innovative treatments like MDMA for PTSD. The chapter warns against a system that may prioritize profit over patient wellness and calls for objective regulatory practices that focus on safety and efficacy.